What is SION's common stock, shares issued (in shares)?

SION (SION) reported common stock, shares issued (in shares) of $45.08M in Q1 2026.

How has SION's common stock, shares issued (in shares) changed year-over-year?

SION's common stock, shares issued (in shares) increased by 2.2% year-over-year, from $44.12M to $45.08M.

SION SION Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Vertex PharmaceuticalsVRTX

——

AbbVieABBV

——

BioCryst PharmaceuticalsBCRX

——

Denali Therapeutics Inc.DNLI

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's common stock, shares issued (in shares)?: SION (SION) reported common stock, shares issued (in shares) of $45.08M in Q1 2026.
How has SION's common stock, shares issued (in shares) changed year-over-year?: SION's common stock, shares issued (in shares) increased by 2.2% year-over-year, from $44.12M to $45.08M.